OncoLog Volume 51, Number 12, December 2006

Authors

Sunni Hosemann, The University of Texas MD Anderson Cancer Center

Files

Contents

• Curable But Not Conquered: Hodgkin’s Lymphoma Today
• House Call: Big Benefits for Smokers Who Quit

Creative Commons License

This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.

Publication Date

12-2006

Publisher

The University of Texas MD Anderson Cancer Center

City

Houston, Texas

Keywords

Fanale, Michelle; Younes, Anas; Wedgwood, Amanda; Rosenblum, Michael G.; Andreeff, Michael, 1943-; Cinciripini, Paul; Hodgkin Disease; Cancer Survivors; Long Term Adverse Effects; ABVD protocol; Antineoplastic Combined Chemotherapy Protocols; Antibodies, Monoclonal; Antigens, CD20; Clinical Trials as Topic; Rituximab; Histone Deacetylases; tanespimycin; Bone Neoplasms -- secondary; Receptors, Vascular Endothelial Growth Factor; Leukemia, Myeloid, Acute; ABT-737; Proto-Oncogene Proteins c-bcl-2; Smoking Cessation; Tobacco Use Cessation; Bupropion; Varenicline; Nicotine.

Disciplines

History of Science, Technology, and Medicine | Oncology

Recommended Citation

Hosemann, Sunni, "OncoLog Volume 51, Number 12, December 2006" (2006). OncoLog MD Anderson's Report to Physicians (All issues). 190.
https://openworks.mdanderson.org/oncolog/190

Conditions Governing Access

Open